Yield of capsule endoscopy in obscure gastrointestinal bleeding: A comparative study between premenopausal and menopausal women

Table 1 Patient characteristics n (%)

No. of patients (n = 183)	All	PMW (30.6%, n = 56)	MW (69.4%, n = 127)	P value1
Age (mean ± SD, yr)	64.3 ± 15.8	43.7 ± 8.0	74.3 ± 7.9	< 0.001
Comorbidities
Chronic kidney disease	24 (13.1)	0 (0)	24 (18.9)	< 0.001
Coronary artery disease	20 (10.9)	3 (5.4)	17 (13.4)	0.11
Heart failure	47 (25.7)	0 (0)	47 (37.0)	< 0.001
Hepatic disease	7 (3.8)	1 (1.8)	6 (4.7)	0.34
Atrial fibrillation	33 (18.0)	2 (3.6)	31 (34.4)	0.001
Drugs
Anticoagulation	35 (19.1)	2 (3.6)	33 (26.0)	< 0.001
Anti-platelet drugs	57 (31.1)	6 (10.7)	51 (40.2)	< 0.001
NSAIDs	61 (33.3)	8 (14.3)	53 (41.7)	< 0.001

¹t -test: χ² test, as appropriate; P value of 0.05 indicating statistical significance; PMW: Premenopausal women; MW: Menopausal women; NSAIDs: Nonsteroidal anti-inflammatory drug.